Press Releases
Keyword Search
02.25.19
OpGen Appoints R. Don Elsey to Board of Directors
02.20.19
OpGen Announces Date of Fourth Quarter and Fiscal Year 2018 Financial Results Conference Call
02.05.19
OpGen Completes Clinical Trials for its Initial FDA 510(k) Submission
12.18.18
OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control
12.04.18
OpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia
11.13.18
OpGen Reports third quarter 2018 Financial Results and Provides Business Update
11.06.18
OpGen Completes Specimen Accrual and Testing in Acuitas® Clinical Verification Study
11.05.18
OpGen Announces Date of Third Quarter 2018 Financial Results Conference Call
10.31.18
OpGen Collaborates With QIAGEN to Advance Rapid Diagnostics for Antimicrobial Resistant Bacteria
10.18.18
OpGen Announces Pricing of Public Offering of Common Stock